{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:36:03Z","timestamp":1785342963794,"version":"3.55.0"},"reference-count":59,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CNS Neurosci Ther"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>There is increasing evidence showing the importance of long\u2010acting injectable antipsychotics in the management of schizophrenia, especially in terms of improving patient medication compliance. A panel of experienced clinicians in Hong Kong mapped out a set of consensus statements with an aim to facilitate the understanding and use of long\u2010acting injectable antipsychotics among local physicians.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eight discussion areas regarding long\u2010acting injectable antipsychotics were selected by the chairman of the consensus group. A series of meetings were held for the panelists to discuss the published literature and their clinical experience, followed by the drafting of consensus statements. At the final meeting, each consensus statement was voted on anonymously by all members based on its practicability of recommendation in Hong Kong.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 12 consensus statements on the rational use of long\u2010acting injectable antipsychotics were established and accepted by the consensus group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The consensus statements aim to provide practical guidance for Hong Kong physicians on the use of long\u2010acting injectable antipsychotics in schizophrenia patients. These statements may also serve as a reference for doctors in other parts of the Asia\u2013Pacific region.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cns.13374","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T06:29:45Z","timestamp":1612938585000},"page":"5-11","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Guidance on the clinical understanding and use of long\u2010acting injectable antipsychotics in Schizophrenia: Hong Kong Consensus Statements"],"prefix":"10.1111","volume":"27","author":[{"given":"Michael Ming Cheuk","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Psychiatry Queen Mary Hospital Pokfulam Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Kar Kin","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Queen Mary Hospital Pokfulam Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Ming Hong","family":"Yeung","sequence":"additional","affiliation":[{"name":"Private Practice Hong Kong City Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Tai Wai","family":"Wong","sequence":"additional","affiliation":[{"name":"Private Practice Hong Kong City Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che Kin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Kowloon Hospital Kowloon Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry Castle Peak Hospital Tuen Mun New Territories Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria Fong Yeung","family":"Chan","sequence":"additional","affiliation":[{"name":"Private Practice Hong Kong City Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Kai Lok","family":"Mak","sequence":"additional","affiliation":[{"name":"Private Practice Hong Kong City Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Oi Yin","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Kowloon Hospital Kowloon Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Man Kin","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Castle Peak Hospital Tuen Mun Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Yan","family":"Mak","sequence":"additional","affiliation":[{"name":"Private Practice Hong Kong City Hong Kong"},{"name":"The Mental Health Association of Hong Kong Private Practice Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2014.06.018"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S49080"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nedt.2012.10.021"},{"key":"e_1_2_7_5_1","first-page":"61","article-title":"Use of biologics for inflammatory bowel disease in Hong Kong: consensus statement","volume":"19","author":"Leung WK","year":"2013","journal-title":"Hong Kong Med J"},{"key":"e_1_2_7_6_1","volume-title":"The Delphi Method: Techniques and Applications","author":"Linstone HA","year":"2002"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06241.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-013-0105-7"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852913000783"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/11208640-000000000-00000"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767110-00003"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)00109-3"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S17177"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.06.029"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.06.036"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2249"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125314540297"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2011.08.010"},{"key":"e_1_2_7_19_1","unstructured":"Janssen Pharmaceuticals Inc.RISPERDAL\u00ae CONSTA\u00ae Prescribing Information. Hong Kong version."},{"key":"e_1_2_7_20_1","unstructured":"Janssen Pharmaceuticals Inc.INVEGA SUSTENNA\u00ae Prescribing Information. Hong Kong version."},{"key":"e_1_2_7_21_1","first-page":"829","article-title":"Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data","volume":"25","author":"Samtani MN","year":"2011","journal-title":"CNS Drugs"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903482772"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2006.09.017"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1115"},{"key":"e_1_2_7_25_1","first-page":"336","article-title":"Rethinking the role of long\u2010acting atypical antipsychotics in the community setting","volume":"27","author":"Altamura AC","year":"2012","journal-title":"Int Clin Psychopharmacol"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-340"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.195.52.s13"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S53795"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.07.003"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0808"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.2217\/npy.11.24"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.10.022"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2008.12.002"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10081224"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05284yel"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2002.02437.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000297663"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820170047006"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318167269d"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32830c2042"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.03.012"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2013.11.1.1"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412470010"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/764769"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/318535"},{"key":"e_1_2_7_46_1","unstructured":"NICE.Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (update). NICE Clinical Guidelines No. 82.London UK:National Institute for Health and Care Excellence 2009."},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.195.52.s63"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000388626.98662.a0"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2012.647345"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/23.4.637"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1007"},{"key":"e_1_2_7_52_1","unstructured":"NICE.Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings. Clinical guideline [CG120] 2011.https:\/\/www.nice.org.uk\/guidance\/cg120. Accessed 25 May 2017."},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108092124"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2008.11.003"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13065su1c.07"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312464106"},{"key":"e_1_2_7_57_1","first-page":"7","article-title":"Haloperidol clearly is neurotoxic. Should it be banned?","volume":"12","author":"Nasrallah HA","year":"2013","journal-title":"Curr Psychiatr"},{"issue":"1","key":"e_1_2_7_58_1","first-page":"S95","article-title":"The differences between typical and atypical antipsychotics: the effects on neurogenesis","volume":"24","author":"Nandra KS","year":"2012","journal-title":"Psychiatr Danub"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300449"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10281"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.13374","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cns.13374","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.13374","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T10:04:55Z","timestamp":1693303495000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cns.13374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":59,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1111\/cns.13374"],"URL":"https:\/\/doi.org\/10.1111\/cns.13374","archive":["Portico"],"relation":{},"ISSN":["1755-5930","1755-5949"],"issn-type":[{"value":"1755-5930","type":"print"},{"value":"1755-5949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"2021-02-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}